RCA
MET icon

Resonant Capital Advisors’s MetLife MET Stock Holding History

Resonant Capital Advisors’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$443K Buy
6,263
+424
+7% +$31.7K 0.02% 288
2025
Q4 		$461K Sell
5,839
-195
-3% -$15.4K 0.03% 256
2025
Q3 		$497K Sell
6,034
-104
-2% -$8.18K 0.03% 250
2025
Q2 		$494K Buy
6,138
+678
+12% +$52.3K 0.03% 241
2025
Q1 		$438K Buy
5,460
+5
+0.1% +$416 0.03% 226
2024
Q4 		$447K Buy
5,455
+15
+0.3% +$1.25K 0.03% 219
2024
Q3 		$449K Sell
5,440
-118
-2% -$8.81K 0.03% 222
2024
Q2 		$390K Buy
5,558
+230
+4% +$16.4K 0.03% 226
2024
Q1 		$395K Buy
5,328
+1,018
+24% +$71K 0.03% 223
2023
Q4 		$285K Buy
4,310
+39
+0.9% +$2.44K 0.03% 241
2023
Q3 		$269K Buy
4,271
+309
+8% +$19.2K 0.03% 230
2023
Q2 		$224K Buy
3,962
+193
+5% +$10.7K 0.02% 244
2023
Q1 		$218K Sell
3,769
-391
-9% -$26.4K 0.02% 236
2022
Q4 		$301K Buy
+4,160
New +$298K 0.04% 214
2022
Q2 		– Sell
-2,952
Closed -$208K – 252
2022
Q1 		$208K Buy
+2,952
New +$200K 0.03% 215

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Resonant Capital Advisors's MET Position: Q1 2026 in Review

Resonant Capital Advisors increased its MetLife (MET) stake by 7.3% in Q1 2026, buying an estimated $31.7K and bringing the position to 6,263 shares worth $443K. The position accounts for 0.02% of the portfolio, ranked #288.

Resonant Capital Advisors first reported a position in MET in Q1 2022 and has held it in 15 quarters since. The position peaked at $497K in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Resonant Capital Advisors held 6,263 shares of MetLife worth $443K as of Q1 2026.
  • Resonant Capital Advisors bought 424 MetLife shares in Q1 2026, an estimated $31.7K.
  • MetLife made up 0.02% of Resonant Capital Advisors's portfolio in Q1 2026, its #288 holding.
  • Resonant Capital Advisors first reported a position in MetLife in Q1 2022 and has held it in 15 quarters since.
  • Resonant Capital Advisors's MetLife position peaked at $497K in Q3 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Resonant Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.